Document Type : Research Article


1 Department of Demography and Geodemography, Faculty of Science, Charles University, Prague, Czech Republic

2 Pregnancy Health Research Canter, Zahedan University of Medical Sciences, Zahedan, Iran

3 Department of Sociology, Faculty of Economics, Management, and Social Sciences, Shiraz University, Shiraz. Iran


Background: A significant proportion of cancer patients use Complementary and Alternative Medicine (CAM) worldwide and especially in Middle Eastern countries. The present study aimed to investigate the prevalence and patterns of using Iranian Traditional Medicine (ITM) and Complementary and Alternative Medicine (CAM) among female cancer patients in Zahedan, southeast of Iran. Also, this study sought to determine whether the patients disclosed the use of ITM and CAM to their physicians.
Methods: In this descriptive-analytical cross-sectional study, 130 female patients, referred to three cancer treatment centers in Zahedan, were selected via the convenience sampling method, from November 2019 to May 2020. Data were collected using a valid and reliable questionnaire. The analysis of data and relationships between the variables was performed using Pearson’s correlation coefficient test, independent samples t-test, and one-way analysis of variance (ANOVA).
Results: Iranian Traditional Medicine (ITM) was highly and moderately used by 14.6% and 62.3% of the patients, respectively; more than 70% of them reported the use of herbal preparations (herbal medicines, medicinal plants, and herbal distillates). Complementary and Alternative Medicine (CAM) was utilized at a moderate level by 91.5% of the participants. The prevalence of diet therapy and the use of vitamins and mineral supplements was over 56% and the increased use of CAM was associated with a higher monthly income. Although 92.3% of the patients were undergoing treatment, a significant percentage of them (80.8%) did not disclose the use of ITM or CAM to their physicians.
Conclusion: The results highlighted the necessity of improving the physician-patient relationship in order to increase the patients’ trust and willingness to consult their physicians about the use of ITM and CAM. Our results also shed light on the need to educate patients about the necessity of consulting a physician about the use of such therapies to minimize the safety concerns.


1. Ali-Shtayeh MS, Jamous RM, Salameh NMY, Jamous RM, Hamadeh AMA. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns. J Ethnopharmacol. 2016;187:104–22. doi: 10.1016/j.jep.2016.04.038. PubMed PMID: 27125594. ## 2. Hamed Abdalla MEA, Ali AM, Loong L. The use of complementary and alternative medicine (CAM) among cancer patients at a tertiary hospital in Malaysia. Complement Ther Med. 2020;50:102343. doi: 10.1016/j.ctim.2020.102343. PubMed PMID: 32444037. ## 3. Molassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655–63. doi: 10.1093/annonc/mdi110. PubMed PMID: 15699021. ## 4. Keene MR, Heslop IM, Sabesan SS, Glass BD. Complementary and alternative medicine use in cancer: A systematic review. Complement Ther Clin Pract. 2019;35:33–47. doi: 10.1016/j.ctcp.2019.01.004. PubMed PMID: 31003679. ## 5. Cevik AB, Akinci AC, Baglama SS. The use of complementary and alternative medicine among lymphoma and cancer patients with a solid tumor: Oncology clinics at Northern and Southern Turkey. Complement Ther Med. 2019;47:102173. doi: 10.1016/j.ctim.2019.08.007. PubMed PMID: 31780026. ## 6. Jazieh AR, Al Sudairy R, Abulkhair O, Alaskar A, Al Safi F, Sheblaq N, et al. Use of complementary and alternative medicine by patients with cancer in Saudi Arabia. J Altern Complement Med. 2012;18(11):1045–9. doi: 10.1089/acm.2011.0266. PubMed PMID: 22906212. ## 7. Bazrafshani MS, Khandani BK, Pardakhty A, Tajadini H, Pour Afshar RM, Moazed V, et al. The prevalence and predictors of using herbal medicines among Iranian cancer patients. Complement Ther Clin Pract. 2019;35:368–373. doi: 10.1016/j.ctcp.2019.03.009. PubMed PMID: 31003684. ## 8. Shirinabadi Farahani A, Salmani N, Khoubbin Khoshnazar TAS, Karami M, Hatamipour K, Yazdani S, et al. The Perspective of Cancer Patients on the Use of Complementary Medicine. Int J Cancer Manag. 2019;12(2):e89916. doi: 10.5812/ijcm.89916. ## 9. Ghaedi F, Dehghan M, Salari M, Sheikhrabori A. Complementary and Alternative Medicines: Usage and Its Determinant Factors Among Outpatients in Southeast of Iran. J Evid Based Complementary Altern Med. 2017;22(2):210–215. doi: 10.1177/2156587215621462. PubMed PMID: 26666436; PubMed Central PMCID: PMC5871173. ## 10. Davis EL, Oh B, Butow PN, Mullan BA, Clarke S. Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist. 2012;17(11):1475-81. doi: 10.1634/theoncologist.2012-0223. PubMed PMID: 22933591; PubMed Central PMCID: PMC3500370. ## 11. Lawshe CH. A quantitative approach to content validity. Personal Psychology. 1975;28:563‑75. doi: 10.1111/j.1744-6570.1975.tb01393.x. ## 12. Yaghmaie F. Content validity and its estimation. J Med Educ. 2003;3(1):e105015. doi: 10.22037/jme.v3i1.870. ## 13. John GM, Hershman DL, Falci L, Shi Z, Tsai W-Y, Greenlee H. Complementary and alternative medicine use among US cancer survivors. J Cancer Surviv. 2016;10(5):850–64. doi: 10.1007/s11764-016-0530-y. PubMed PMID: 26920872; PubMed Central PMCID: PMC5001939. ## 14. Sheikhrabori A, Dehghan M, Ghaedi F, Khademi GR. Complementary and Alternative Medicine Usage and Its Determinant Factors Among Diabetic Patients: An Iranian Case. J Evid Based Complementary Altern Med. 2017;22(3):449-454. doi: 10.1177/2156587216675079. PubMed PMID: 27821612; PubMed Central PMCID: PMC5871159. ## 15. Molassiotis A, Scott JA, Kearney N, Pud D, Magri M, Selvekerova S, et al. Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer. 2006;14(3):260–7. doi: 10.1007/s00520-005-0883-7. PubMed PMID: 16143871. ## 16. Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187–203. doi: 10.1177/1534735411423920. PubMed PMID: 22019489. ## 17. Lotfi M-S, Adib-Hajbaghery M, Shahsavarloo ZR, Gandomani HS. The prevalence of traditional and complementary medicine in the general population in Kashan, Iran, 2014. European Journal of Integrative Medicine. 2016;8(5):661–669. doi: 10.1016/j.eujim.2016.06.006. ## 18. Tehrani Banihashemi SA, Asgharifard H, Haghdoost AA, Barghmadi M, Mohammadhosseini N. The use of complementary/alternative medicine among the general population in Tehran, Iran. Payesh. 2008;7(4):355–362. Persian. ## 19. Movahed M, Rayanpour R. Study of usage rate for various complementary and alternative medicine among people visited non-conventional medical centers in Shiraz, Iran, in 2016. Bangladesh Journal of Medical Science. 2019;18(2):294-302. doi: 10.3329/bjms.v18i2.40700. ## 20. Sadighi J, Maftoon F, Moshrefi M. Complementary and alternative medicine (CAM): Knowledge, attitude and practice in Tehran, Iran. Payesh. 2004;3(4):279-289. Persian. ## 21. Poonthananiwatkul B, Howard RL, Williamson EM, Lim RHM. Cancer patients taking herbal medicines: a review of clinical purposes, associated factors, and perceptions of benefit or harm. J Ethnopharmacol. 2015;175:58–66. doi: 10.1016/j.jep.2015.08.052. PubMed PMID: 26344852. ## 22. Movahed M, Salehi A, Rayanpour R. Quality of Doctor-Patient Relationship and its Effect on Usage of Traditional and Complementary Medicine. Journal of Isfahan Medical School. 2017;35(421):177–85. Persian. ## 23. Naja F, Fadel RA, Alameddine M, Aridi Y, Zarif A, Hariri D, et al. Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: A cross-sectional study. BMC Complement Altern Med. 2015;15:444. doi: 10.1186/s12906-015-0969-9. PubMed PMID: 26692096; PubMed Central PMCID: PMC4687122. ## 24. O’Beirne M, Verhoef M, Paluck E, Herbert C. Complementary therapy use by cancer patients. Physicians’ perceptions, attitudes, and ideas. Can Fam Physician. 2004;50:882–8. PubMed PMID: 15233371; PubMed Central PMCID: PMC2214623. ##